Aurora has an acquisition agreement with Organigram, and Curaleaf still has a hostile offer open. No offer terms or final choice are reported, so the story does not show which path helps Aurora.
That leaves Aurora facing competing ownership paths, but the story gives no offer terms or final decision. Curaleaf's criticism shows the dispute is contested, not which outcome would help Aurora.
Follow Aurora Cannabis (ACB) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ACB